VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2017

Nov 7, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2017-11-03

Reporting Person: SMITH IAN F (EVP, COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-03	Common Stock	M	2155	$91.05	Acquired	43043	Direct
2017-11-03	Common Stock	S	2155	$150.00	Disposed	40888	Direct
2017-11-06	Common Stock	M	4250	$77.31	Acquired	45138	Direct
2017-11-06	Common Stock	S	4250	$150.00	Disposed	40888	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-03	Stock Option (Right to Buy)	$91.05	M	2155	Disposed	2026-02-01	Common Stock (2155)	Direct
2017-11-06	Stock Option (Right to Buy)	$77.31	M	4250	Disposed	2024-02-04	Common Stock (4250)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5306	Indirect

Footnotes

F1: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.

F2: The option vests in 16 quarterly installments from 2/2/2016.

F3: The option vests in 16 quarterly installments from 2/5/2014.